Sharp Therapeutics Corp. (SHRX : TSX-V)
Common Stock
$1.37
CAD
+0.46 (50.55%)
Last updated: 2026-09-08
Get SHRX alerts:
SHRX
Sharp Therapeutics Corp.
WealthAwesomePerformance
1 Day
+50.55%
1 Week
+50.55%
1 Month
+50.55%
YTD
-19.41%
Key Statistics
Market Cap
$28.73M
52W High
$5.00
52W Low
$0.25
P/E Ratio
-
50 Day MA
$0.91
200 Day MA
$1.89
Beta
-0.71
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/8/2026 | $1.38 | $1.38 | $1.37 | $1.37 | $1.37 | 2,800 |
| 7/3/2026 | $0.91 | $0.91 | $0.91 | $0.91 | $0.91 | 0 |
| 7/2/2026 | $0.91 | $0.91 | $0.91 | $0.91 | $0.91 | 0 |
| 6/30/2026 | $0.91 | $0.91 | $0.91 | $0.91 | $0.91 | 1,300 |
| 6/29/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/26/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/25/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/24/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/23/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
| 6/22/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | 0 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SHRX's historical volatility
30-Day Vol
250.2%
Annualized
90-Day Vol
144.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.15
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.29 | C$0.54 – C$3.06 |
| 60 trading days | C$1.22 | C$0.36 – C$4.12 |
| 90 trading days | C$1.15 | C$0.26 – C$5.11 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Sharp Therapeutics Corp.
Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies that allows the creation of sensitive assays mimicking the genetic disease state, enabling discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically; and Mine, a custom-built, cloud-distributed analytics platform that captures data for AlloChem compounds in CoreX assays. Sharp Therapeutics Corp. is headquartered in Pittsburgh, Pennsylvania.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-5.58M
- Profit Margin
- 0.00%
- ROE (TTM)
- -3762.21%
- EPS (Diluted)
- -0.24
- Book Value
- -0.10
🔄 Recent Splits
1-for-10
Jan 27, 2025
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About SHRX
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| CES-P | Celestial Acquisition Corp. | $0.20 | +185.71% |
| DDD | Metavista3D Inc. | $0.36 | +78.05% |
| SRA | Stria Lithium Inc | $1.15 | +47.44% |
| ATR-P | Aster Acquisition Corp. | $0.10 | +46.15% |
| RKV | Rakovina Therapeutics Inc | $0.32 | +45.45% |
| AAAJ-P | AAJ Capital 3 Corp. | $0.04 | +40.00% |
| FRNT | FRNT Financial Inc | $0.06 | +37.50% |
| PHD | Providence Gold Mines | $0.06 | +37.50% |
SHRX.V news timeline
1 article covering SHRX.V, most recent first
Latest